164 related articles for article (PubMed ID: 25316816)
1. Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responses.
Shi Y; Liu X; Lou J; Han X; Zhang L; Wang Q; Li B; Dong M; Zhang Y
Clin Cancer Res; 2014 Dec; 20(23):6016-22. PubMed ID: 25316816
[TBL] [Abstract][Full Text] [Related]
2. Plasma Heat Shock Protein 90 Alpha: A Valuable Predictor of Early Chemotherapy Effectiveness in Advanced Non-Small-Cell Lung Cancer.
Zhong B; Shen J; Zhang C; Zhou G; Yu Y; Qin E; Tang J; Wu D; Liang X
Med Sci Monit; 2021 Jan; 27():e924778. PubMed ID: 33419959
[TBL] [Abstract][Full Text] [Related]
3. Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial.
Fu Y; Xu X; Huang D; Cui D; Liu L; Liu J; He Z; Liu J; Zheng S; Luo Y
EBioMedicine; 2017 Oct; 24():56-63. PubMed ID: 28939487
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of plasma HSP90α levels for detection of hepatocellular carcinoma.
Wei W; Liu M; Ning S; Wei J; Zhong J; Li J; Cai Z; Zhang L
BMC Cancer; 2020 Jan; 20(1):6. PubMed ID: 31898536
[TBL] [Abstract][Full Text] [Related]
5. A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic.
Liu W; Li J; Zhang P; Hou Q; Feng S; Liu L; Cui D; Shi H; Fu Y; Luo Y
Cancer Sci; 2019 Sep; 110(9):2941-2959. PubMed ID: 31343810
[TBL] [Abstract][Full Text] [Related]
6. Plasma heat shock protein 90-alpha have an advantage in diagnosis of colorectal cancer at early stage.
Kasanga M; Liu L; Xue L; Song X
Biomark Med; 2018 Aug; 12(8):881-890. PubMed ID: 29939072
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of plasma heat shock protein 90alpha in gastric cancer.
Liang XQ; Li KZ; Li Z; Xie MZ; Tang YP; Du JB; Huang Y; Li JL; Hu BL
Int Immunopharmacol; 2021 Jan; 90():107145. PubMed ID: 33162344
[TBL] [Abstract][Full Text] [Related]
8. Value of HSP90α in Lung Cancer Diagnosis and Recurrence Prediction: A Cohort Study.
Wang Y; Seyed Barghi SM; Yang Y; Akhavan-Sigari R
Oncol Res Treat; 2021; 44(11):583-589. PubMed ID: 34547748
[TBL] [Abstract][Full Text] [Related]
9. Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: in patients with different clinicopathologic characteristics.
Han Y; Zhang Y; Cui L; Li Z; Feng H; Zhang Y; Sun D; Ren L
World J Surg Oncol; 2021 Aug; 19(1):228. PubMed ID: 34348726
[TBL] [Abstract][Full Text] [Related]
10. Potential predictive value of plasma heat shock protein 90α in lung cancer.
Li X; Tong X; Liu B; Li Z; Ding J; Li J; Zheng M; Tian Y; Yan S; Huang M; Ge J
J Int Med Res; 2021 Dec; 49(12):3000605211064393. PubMed ID: 34904468
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of Hsp90α in monitoring treatment responses in lung cancer.
Wang M; Jıang Z; Lıu R
Turk J Med Sci; 2022 Jun; 52(3):747-753. PubMed ID: 36326305
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of HSP90α and related markers in lung cancer.
Yuan Z; Wang L; Hong S; Shi C; Yuan B
J Clin Lab Anal; 2022 Jun; 36(6):e24462. PubMed ID: 35522136
[TBL] [Abstract][Full Text] [Related]
13. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
[TBL] [Abstract][Full Text] [Related]
14. Impact of HSP90
Zhou W; Yang Y; Wang Z; Liu Y; Lari Najafi M
J Healthc Eng; 2021; 2021():6929971. PubMed ID: 34721827
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of tumor markers in bronchoalveolar lavage fluid for the peripheral pulmonary carcinoma.
Zhang S; Zhao YF; Zhang MZ; Wu XL
Clin Respir J; 2017 Jul; 11(4):481-488. PubMed ID: 26260621
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of heat shock protein 90α expression as a biomarker of prognosis in patients with gastric cancer.
Lee HW; Kim KM
Niger J Clin Pract; 2019 Dec; 22(12):1698-1705. PubMed ID: 31793477
[TBL] [Abstract][Full Text] [Related]
17. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
Zhang YL; Zhang ZL; Zhu XB; Xu L; Lu P; Xu M; Liu WJ; Zhang XY; Yao HM; Ye XW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
Su K; Zhang T; Wang Y; Hao G
World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of heat shock protein 90α in malignant melanoma.
Zhang T; Li Q; Zhang Y; Wang Q; Wang H; Gu K
Melanoma Res; 2021 Apr; 31(2):152-161. PubMed ID: 33492051
[TBL] [Abstract][Full Text] [Related]
20. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
